当前位置: 首页 >> 检索结果
共有 38745 条符合本次的查询结果, 用时 2.5019701 秒

1041. Response.

作者: Anthony D Bai.
来源: Chest. 2024年166卷1期e21-e22页

1042. Progressive Dyspnea in a Woman With Tracheal Stenosis and Rheumatoid Arthritis.

作者: Eugene Shostak.;Rutvi Amin.;Genna Braverman.;Sharon Steinberger.;Cynthia Magro.
来源: Chest. 2024年166卷1期e15-e20页
An 82-year-old woman with a remote tracheostomy due to vocal cord paralysis and long-standing erosive, seropositive rheumatoid arthritis (RA) well controlled with methotrexate sought treatment at the ED with 1 month of dyspnea, chest tightness, and cough productive of blood-tinged sputum. She had been treated unsuccessfully as an outpatient with multiple courses of antibiotics. She did not smoke or drink alcohol and had no recent travel outside the country. Given concern for airway compromise, she was admitted to the hospital.

1043. A Middle-Aged Woman With a Nonsignificant Medical History Experienced a Sudden Acute Myocardial Infarction.

作者: Xuehui Gao.;Ruiting Li.;Yongran Wu.;Xiaojing Zou.;You Shang.
来源: Chest. 2024年166卷1期e11-e14页

1044. Group 5 Pulmonary Hypertension Associated With T-Cell Large Granular Lymphocytic Leukemia: Hemodynamics and Treatment.

作者: Daniel J Strick.;Harrison W Farber.;Nicholas S Hill.;Ioana R Preston.;Natasha M Pradhan.;Bipin Malla.
来源: Chest. 2024年166卷1期e1-e3页
Group 5 pulmonary hypertension (PH) encompasses diverse diseases, with a few cases linking it to T-cell large granular lymphocytic (LGL) leukemia. We report a case of a 76-year-old woman, diagnosed with LGL leukemia and concomitant PH, treated with oral triple pulmonary arterial hypertension (PAH) therapy. She initially presented with dyspnea on exertion; evaluation revealed severe precapillary PH. Implementing cyclophosphamide for leukemia along with tadalafil and macitentan for PH led to sustained symptomatic and hemodynamic improvement for over 3 years. At that time, deterioration in PH prompted the addition of selexipag, resulting in sustained clinical improvement for an additional 5 years. This case exemplifies the potential for sustained benefits of PAH therapy in leukemia-associated PH and highlights the need for continued research on the mechanistic relationship between LGL leukemia and PH, with the hope of identifying new management strategies.

1045. A Detailed Mechanistic Understanding of Positional and Nonpositional OSA: What Side Are You On?

作者: Bradley A Edwards.;Simon A Joosten.;Scott A Sands.
来源: Chest. 2024年166卷1期7-9页

1046. Breaking Down Barriers in Vaccine Coverage.

作者: Ryan C Maves.;Bhavita Gaglani.
来源: Chest. 2024年166卷1期5-6页

1047. International Severe Asthma Registry: Closer to the Full Picture of Asthma Care and Outcomes?

作者: Eric Van Ganse.;Renaud Louis.
来源: Chest. 2024年166卷1期3-4页

1048. Corrigendum to: Chest. 2023;164(6):1444-1453.

来源: Chest. 2024年166卷1期240页

1049. Corrigendum to: Chest. 2024;165(2):250-252.

来源: Chest. 2024年166卷1期240页

1050. Global Initiative for Chronic Obstructive Lung Disease and Canadian Thoracic Society COPD Guidelines: Two Sides of the Same Coin or Different Coins?

作者: Jean Bourbeau.;Don D Sin.
来源: Chest. 2024年166卷1期24-27页

1051. Rebuttal From Dr Suissa.

作者: Samy Suissa.
来源: Chest. 2024年166卷1期21-23页

1052. Rebuttal From Drs Adrish and Hanania.

作者: Muhammad Adrish.;Nicola A Hanania.
来源: Chest. 2024年166卷1期20-21页

1053. The Mountain.

作者: Avraham Z Cooper.
来源: Chest. 2024年166卷1期187-189页

1054. COUNTERPOINT: Should Triple Inhaled Therapy Be Considered in All Patients With Group E COPD? No.

作者: Samy Suissa.
来源: Chest. 2024年166卷1期17-20页

1055. POINT: Should Triple Inhaled Therapy Be Considered in All Patients With Group E COPD? Yes.

作者: Muhammad Adrish.;Nicola A Hanania.
来源: Chest. 2024年166卷1期12-17页

1056. Exploring the Intersection of Reproductive Factors and Lung Cancer Risk in Female Patients.

作者: Patrick M Meyers.;Michael N Kammer.
来源: Chest. 2024年166卷1期10-11页

1057. Thank You for the Opportunity.

作者: Peter J Mazzone.
来源: Chest. 2024年166卷1期1-2页

1058. Eosinopenia as Predictor of Disease Severity in Patients With Community-Acquired Pneumonia: An Observational Study.

作者: Barbara Christine Weckler.;Hendrik Pott.;Alan Race.;Nattika Jugkaeo.;Kapil Karki.;Stephan Ringshandl.;Christian Seidemann.;Ines Schöndorf.;Harald Renz.;Sebastian Fähndrich.;Anna Lena Jung.;Wilhelm Bertrams.;Adeline Makoudjou.;Daniela Zöller.;Susetta Finotto.;Stefanie Schild.;Susanne A Seuchter.;Gernot Rohde.;Frederik Trinkmann.;Timm Greulich.;Claus Franz Vogelmeier.;Bernd Schmeck.
来源: Chest. 2024年166卷6期1329-1333页

1059. Comparison of Early and Late Norepinephrine Administration in Patients With Septic Shock: A Systematic Review and Meta-Analysis.

作者: Chiwon Ahn.;Gina Yu.;Tae Gun Shin.;Youngsuk Cho.;Sunghoon Park.;Gee Young Suh.
来源: Chest. 2024年166卷6期1417-1430页
Vasopressor administration at an appropriate time is crucial, but the optimal timing remains controversial.

1060. Association Between Spontaneous Breathing Trial Methods and Reintubation in Adult Critically Ill Patients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

作者: Mariachiara Ippolito.;Salvatore Sardo.;Vincenzo Francesco Tripodi.;Nicola Latronico.;Elena Bignami.;Antonino Giarratano.;Andrea Cortegiani.
来源: Chest. 2024年166卷5期1020-1034页
Reintubation is associated with higher risk of mortality. There is no clear evidence on the best spontaneous breathing trial (SBT) method to reduce the risk of reintubation.
共有 38745 条符合本次的查询结果, 用时 2.5019701 秒